Table 2.
Indications of renal biopsy
| Indications | DN | NDRD plus DN | NDRD |
|---|---|---|---|
| Patients, n (%) | 329 (39.5) | 90 (10.8) | 413 (49.6) |
| Nephrotic syndrome or fast increase of proteinuria, n (%) | 138 (52.9) | 28 (10.7) | 95 (36.4) |
| Abrupt decrease in eGFR in patient with stable renal function, n (%) | 76 (43.9) | 21 (12.1) | 76 (43.9) |
| AKI, n (%) | 23 (19.5) | 17 (14.4) | 78 (66.1) |
| Nephrotic proteinuria without DR, n (%) | 36 (40.4) | 7 (7.0) | 46 (51.7) |
| Signs of symptoms of systemic disease, n (%) | 13 (24.5) | 4 (7.5) | 36 (67.9) |
| Proteinuria >1 g in DM with <5 years of evolution, n (%) | 16 (34.8) | 5 (10.9) | 25 (54.3) |
| Micro/macrohaematuria, n (%) | 11 (26.2) | 5 (11.9) | 26 (61.9) |
| Nephrotic proteinuria with DM <5 years of evolution, n (%) | 6 (33.3) | 1 (5.6) | 11 (61.1) |
| Others, n (%) | 10 (31.3) | 2 (6.3) | 20 (62.5) |
AKI, acute kidney injury.